BioCentury
ARTICLE | Strategy

Shaman inverts its drug development model

November 14, 1994 8:00 AM UTC

Noteworthy

With its long-term capital security in mind, Shaman Pharmaceuticals Inc. has decided to focus on the pharmaceutical industry as its primary customer and will concentrate its development efforts in diseases best modeled by whole animal testing. ...